Patient Age and Extent of Liver Resection Influence Outcome of Liver Resection for Hepatocellular Carcinoma in Non-Cirrhotic Liver

被引:9
|
作者
Faber, Wladimir [1 ]
Sharafi, Siamak [1 ]
Stockmann, Martin [1 ]
Dennecke, Timm [2 ]
Bahra, Marcus [1 ]
Klein, Fritz [1 ]
Malinowski, Maciej B. [1 ]
Schott, Eckart [3 ]
Neuhaus, Peter [1 ]
Seehofer, Daniel [1 ]
机构
[1] Charite, Dept Gen Visceral & Transplantat Surg, Campus Virchow Klinikum, D-13353 Berlin, Germany
[2] Charite, Dept Radiol, D-13353 Berlin, Germany
[3] Charite, Dept Hepatol, D-13353 Berlin, Germany
关键词
Liver; hepatocellular carcinoma; clinical course; LONG-TERM SURVIVAL; PROGNOSTIC-FACTORS; HEPATIC RESECTION; NONALCOHOLIC STEATOHEPATITIS; CANCER; TRANSPLANTATION; CIRRHOSIS; RISK; CLASSIFICATION; RECURRENCE;
D O I
10.5754/hge13667
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Backgrouind/Aims: Data about the clinical course after liver resection for HCC in non-cirrhotic liver (NCL) is rare in western countries. Although the patients with HCC in NCL tolerate major liver resections, it is less clear if an underlying steatosis or NASH increase the perioperative and postoperative risk. The purpose of this study was to characterize the clinical course after hepatic re!section in patients with HCC in the absence of liver cirrhosis and in the absence of viral hepatitis. Methodology: The data of 148 patients with HCC in non-cirrhotic liver, who underwent curatively intented liver resection, were analyzed. Patients with hepatitis B or C infection were excluded. Patients with fibrolamellar HCC or liver cirrhosis or fibrosis higher than grade 2 according to the Desmet-Scheuer score were also excluded. Results: 'The overall 1-, 3- and 5-year survival rates were 75.4%, 54.7% and 38.9%. Increased patient age (elder than 70 years) influenced the cumulative survival significantly. Especially the combination of increased patient age and major resection (>2 segments) at once influenced tliel cumulative survival. The overall postoperative morbidity was 37.8 %. No intraoperative death was observed Postoperative increased leucocytes, urea and creatininl increased the postoperative complications. In the subi group with major resection increased GGT correlated: with steatosis, and raised AST correlated with elevated ! patient age. Conclusions: In Western countries HCC non-cirrhotic liver is rare. Liver resection is safe and is the only curative therapy option for the time by HCCI without liver cirrhosis. Further studies are necessary] for identification of more prognostic factors and option.' ally special treatment.
引用
收藏
页码:1925 / 1930
页数:6
相关论文
共 50 条
  • [1] Liver resection for hepatocellular carcinoma in patients with normal, non-normal non-cirrhotic and cirrhotic liver
    Zanella, M. C.
    Toso, C.
    Rubbia-Brandt, L.
    Giostra, E.
    Terraz, S.
    Majno, P.
    Mentha, G.
    SWISS MEDICAL WEEKLY, 2010, 140 : 20S - 20S
  • [2] Liver resection for hepatocellular carcinoma in non-cirrhotic liver without underlying viral hepatitis
    Lang, H
    Sotiropoulos, GC
    Dömland, M
    Frühauf, NR
    Paul, A
    Hüsing, J
    Malagó, M
    Broelsch, CE
    BRITISH JOURNAL OF SURGERY, 2005, 92 (02) : 198 - 202
  • [3] Liver resection for non-cirrhotic hepatocellular carcinoma in South African patients
    Bhaijee, F.
    Krige, J. E. J.
    Locketz, M. L.
    Kew, M. C.
    SOUTH AFRICAN JOURNAL OF SURGERY, 2011, 49 (02) : 68 - 74
  • [4] Good outcomes after resection of large hepatocellular carcinoma in the non-cirrhotic liver
    Verhoef, C
    de Man, RA
    Zondervan, PE
    Eijkemans, MJC
    Tilanus, HW
    IJzermans, JNM
    DIGESTIVE SURGERY, 2004, 21 (5-6) : 380 - 386
  • [5] Liver transplantation for intrahepatic recurrence of hepatocellular carcinoma in non-cirrhotic livers after partial liver resection
    Mergental, Hynek
    Adam, Rene
    Klempnauer, Jurgen L.
    Broelsch, Christopher
    Castaing, Denis
    Muehlbacher, Ferninand
    Rogiers, Xavier
    Sellez, Carlos F.
    Lerut, Jan
    Hockerstedt, Krister
    Slooff, Maarten J. H.
    Mazzaferro, Vincenzo
    Ericzon, Bo-Goran
    Le Treut, Yves P.
    Kalicinski, Piotr
    Krawczyk, Marek
    Mantion, Georges
    Jamieson, Neville
    Muiesan, Paolo
    Wolff, Martin
    Langrehr, Jan
    Porte, Robert J.
    TRANSPLANT INTERNATIONAL, 2007, 20 : 5 - 5
  • [6] Hepatocellular carcinoma in cirrhotic and non-cirrhotic liver
    Janevska, V.
    Jovanovik, R.
    Perushevska, G.
    Ivanova, V. Chalovska
    Dimitrova, M. Genadieva
    Janevska, D.
    VIRCHOWS ARCHIV, 2018, 473 : S127 - S127
  • [7] Hepatocellular carcinoma in the non-cirrhotic liver
    Evert, M.
    Dombrowski, F.
    PATHOLOGE, 2008, 29 (01): : 47 - 52
  • [8] Hepatocellular carcinoma in the non-cirrhotic liver
    Dong, Yi
    Wang, Wen-Ping
    Lee, Won Jae
    Meloni, Maria Franca
    Clevert, Dirk-Andre
    Chammas, Maria Cristina
    Tannapfel, Andrea
    Forgione, Antonella
    Piscaglia, Fabio
    Dietrich, Christoph Frank
    CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 2022, 80 (04) : 423 - 436
  • [9] Treatment of hepatocellular carcinoma in the cirrhotic and non-cirrhotic liver
    Schmelzle, M.
    Krenzien, F.
    Schoening, W.
    Pratschke, J.
    CHIRURG, 2018, 89 (11): : 851 - 857
  • [10] Hepatocellular carcinoma in non-cirrhotic liver: A reappraisal
    Trevisani, Franco
    Frigerio, Marta
    Santi, Valentina
    Grignaschi, Alice
    Bernardi, Mauro
    DIGESTIVE AND LIVER DISEASE, 2010, 42 (05) : 341 - 347